Hepatic miR-33a/miR-144 and their target geneABCA1are associated with steatohepatitis in morbidly obese subjects

Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats

(2015) Dongmin Li et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Expression of Liver X Receptor Correlates with Intrahepatic Inflammation and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

(2014) Sang Bong Ahn et al.   DIGESTIVE DISEASES AND SCIENCES

Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144

(2013) Cristina M. Ramírez et al.   CIRCULATION RESEARCH

Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice

(2013) Kengo Tomita et al.   HEPATOLOGY

Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes

(2013) Wei Liu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Contribution of Common Genetic Variants to Obesity and Obesity-Related Traits in Mexican Children and Adults

(2013) Paola León-Mimila et al.   PLoS One

Pharmacological Inhibition of a MicroRNA Family in Nonhuman Primates by a Seed-Targeting 8-Mer AntimiR

(2013) V. Rottiers et al.   Science Translational Medicine

Non-alcoholic steatohepatitis in morbidly obese patients

(2013) Albert Tran et al.   Clinics and Research in Hepatology and Gastroenterology

Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease

(2012) Hae-Ki Min et al.   Cell Metabolism

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

(2012) Giovanni Musso et al.   PROGRESS IN LIPID RESEARCH

Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARγ/LXRα pathway: Findings from in vitro and ex vivo studies

(2011) Hideki Ozasa et al.   ATHEROSCLEROSIS

Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis

(2011) Derrick M. Van Rooyen et al.   GASTROENTEROLOGY

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis

(2011) Katey J. Rayner et al.   JOURNAL OF CLINICAL INVESTIGATION

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides

(2011) Katey J. Rayner et al.   NATURE

Type 2 Diabetes Is Associated with Reduced ATP-Binding Cassette Transporter A1 Gene Expression, Protein and Function

(2011) Dipesh C. Patel et al.   PLoS One

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

(2011) A. Davalos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells

(2010) Yanhong Yang et al.   BIOCHIMIE

miR-33 links SREBP-2 induction to repression of sterol transporters

(2010) T. J. Marquart et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

(2010) K. J. Rayner et al.   SCIENCE

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH

(2009) Francisco Caballero et al.   JOURNAL OF HEPATOLOGY

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages

(2008) Kazumi Tsubakio-Yamamoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS